La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Henry Schein Dividendo

Dividendo criteri di controllo 0/6

Henry Schein non ha registrato alcun pagamento di dividendi.

Informazioni chiave

n/a

Rendimento del dividendo

n/a

Rapporto di remunerazione

Rendimento medio del settore	1.6%
Prossima data di pagamento dei dividendi	n/a
Data di stacco del dividendo	n/a
Dividendo per azione	n/a
Utile per azione	US$2.78
Previsione del rendimento del dividendo a 3 anni	0%

Aggiornamenti recenti sui dividendi

Nessun aggiornamento

Recent updates

There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Apr 14

Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward

Feb 28

Is Henry Schein (NASDAQ:HSIC) A Risky Investment?

Oct 11

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Sep 23

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?

Aug 21

Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively

Aug 01

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Jul 09

At US$74.94, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely?

Jun 09

Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 36%?

May 21

Henry Schein (NASDAQ:HSIC) Hasn't Managed To Accelerate Its Returns

May 01

Here's Why Henry Schein (NASDAQ:HSIC) Can Manage Its Debt Responsibly

Apr 10

Estimating The Intrinsic Value Of Henry Schein, Inc. (NASDAQ:HSIC)

Feb 15

Returns On Capital At Henry Schein (NASDAQ:HSIC) Have Stalled

Jan 28

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Jan 10

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Dec 11

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 43% Undervaluation?

Nov 04

Buy Henry Schein To Receive 'Resiliency Premium' In Equity Portfolios

Aug 25

Henry Schein announces $400M increase to stock buyback plan

Aug 18

If EPS Growth Is Important To You, Henry Schein (NASDAQ:HSIC) Presents An Opportunity

Aug 09

Henry Schein Q2 2022 Earnings Preview

Aug 01

Be Wary Of Henry Schein (NASDAQ:HSIC) And Its Returns On Capital

Jul 04

Does Henry Schein (NASDAQ:HSIC) Have A Healthy Balance Sheet?

Jun 14

Henry Schein: Neutral On Valuation, Covid-19 Sales Slowdown

Jun 09

Henry Schein, Inc. (NASDAQ:HSIC) Shares Could Be 45% Below Their Intrinsic Value Estimate

May 27

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: Dati insufficienti per determinare se i dividendi per azione di HSIC siano rimasti stabili in passato.

Dividendo in crescita: Dati insufficienti per determinare se i pagamenti dei dividendi di HSIC siano aumentati.

Rendimento dei dividendi rispetto al mercato

Henry Schein Rendimento dei dividendi rispetto al mercato

Come si colloca il rendimento da dividendo di HSIC rispetto al mercato?
Segmento	Rendimento dei dividendi
Azienda (HSIC)	n/a
Fondo del 25% del mercato (US)	1.4%
Top 25% del mercato (US)	4.3%
Media del settore (Healthcare)	1.6%
Previsione dell'analista in 3 anni (HSIC)	0%

Dividendo notevole: Impossibile valutare il rendimento dei dividendi di HSIC rispetto al 25% inferiore dei pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.

Dividendo elevato: Impossibile valutare il rendimento dei dividendi di HSIC rispetto al 25% dei maggiori pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.

Distribuzione degli utili agli azionisti

Copertura degli utili: Dati insufficienti per calcolare il payout ratio di HSIC per determinare se i suoi pagamenti di dividendi sono coperti dagli utili.

Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: Impossibile calcolare la sostenibilità dei dividendi poiché HSIC non ha segnalato alcun pagamento.

Henry Schein Dividendo

Dividendo criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sui dividendi

Recent updates

Henry Schein (NASDAQ:HSIC) Will Be Hoping To Turn Its Returns On Capital Around

Consensus EPS estimates fall by 12%

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Is It Time To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?

Henry Schein, Inc. to Report Q2, 2024 Results on Aug 06, 2024

Market Participants Recognise Henry Schein, Inc.'s (NASDAQ:HSIC) Earnings

Henry Schein: Acquisition Strategy Isn't Pulling Its Economic Weight

Here's Why Henry Schein (NASDAQ:HSIC) Has A Meaningful Debt Burden

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Is It Too Late To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?

There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Henry Schein, Inc. to Report Q1, 2024 Results on May 07, 2024

Henry Schein, Inc. Announces Appointment of Members to the Company’S Executive Management Committee

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority interest in TriMed, Inc.

Insider recently sold US$478k worth of stock

Henry Schein, Inc., Annual General Meeting, May 21, 2024

Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward

Full year 2023 earnings: EPS misses analyst expectations

Henry Schein, Inc. Presents Comprehensive Lineup of Solutions At the 2024 Chicago Dental Society Mid Winter Meeting

Henry Schein, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire an unknown majority interest in TriMed, Inc.

Henry Schein Appoints Carole T. Faig as New Independent Director

Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Henry Schein, Inc. Provides Earnings Guidance for 2023

Henry Schein, Inc. announced delayed 10-Q filing

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority stake in Shield HealthCare, Inc.

Is Henry Schein (NASDAQ:HSIC) A Risky Investment?

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?

Henry Schein, Inc. Affirms Earnings Guidance for the Full Year of 2023

New minor risk - Earnings quality

Second quarter 2023 earnings: EPS misses analyst expectations

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire a majority stake in Shield HealthCare, Inc.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired a majority stake in Large Practice Sales LLC.

Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively

Henry Schein, Inc. to Report Q2, 2023 Results on Aug 07, 2023

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Insider recently sold US$835k worth of stock

At US$74.94, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely?

Executive Vice Chairman & President notifies of intention to sell stock

Executive VP & COO notifies of intention to sell stock

Executive VP recently sold US$1.9m worth of stock

Executive VP notifies of intention to sell stock

Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 36%?

Henry Schein, Inc. Provides Sales Guidance for the Fiscal Year 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) agreed to acquire SIN - Sistema de Implante Nacional S.A. from Southern Cross Group.

Henry Schein (NASDAQ:HSIC) Hasn't Managed To Accelerate Its Returns

Here's Why Henry Schein (NASDAQ:HSIC) Can Manage Its Debt Responsibly

Independent Director recently sold US$148k worth of stock

Senior VP & Chief Legal Officer notifies of intention to sell stock

Independent Lead Director recently sold US$504k worth of stock

Independent Lead Director notifies of intention to sell stock

Independent Director recently sold US$923k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Henry Schein, Inc. Reports Impairment Charge on Intangible Assets for the Fourth Quarter Ended December 31, 2022

Now 25% undervalued

Estimating The Intrinsic Value Of Henry Schein, Inc. (NASDAQ:HSIC)

Henry Schein, Inc. (NasdaqGS:HSIC) announces an Equity Buyback for $400 million worth of its shares.

Returns On Capital At Henry Schein (NASDAQ:HSIC) Have Stalled

Henry Schein, Inc. to Report Q4, 2022 Results on Feb 16, 2023

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Insider recently sold US$1.2m worth of stock

Now 21% undervalued

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 43% Undervaluation?

Henry Schein, Inc. to Report Q3, 2022 Results on Nov 01, 2022

Henry Schein, Inc. Announces its Lineup of Products and Solutions At the American Association of Oral and Maxillofacial Surgeons (AAOMS) Annual Conference in New Orleans, La. from September 12 Through September 17

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Midway Dental Supply, Inc.

Buy Henry Schein To Receive 'Resiliency Premium' In Equity Portfolios